Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors

References

• Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H. Combination therapy in combating cancer. Oncotarget. 2017;8(23):38022–38043.
   PubMedGoogle Scholar
• Anighoro A, Bajorath J, Rastelli G. Polypharmacology: challenges and opportunities in drug discovery: miniperspective. J Med Chem. 2014;57(19):7874–7887.
   PubMed Web of Science ®Google Scholar
• Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther. 2020;206:107447.
   PubMed Web of Science ®Google Scholar
• Longley DB, Latif T, Boyer J, Allen WL, Maxwell PJ, Johnston PG. The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells. Semin Oncol. 2003;30(3 Suppl 6):3–9.
   PubMed Web of Science ®Google Scholar
• Newby Z, Lee TT, Morse RJ, Liu Y, Liu L, Venkatraman P, Santi DV, Finer-Moore JS, Stroud RM. The role of protein dynamics in thymidylate synthase catalysis: variants of conserved 2’-deoxyuridine 5’-monophosphate (dUMP)-binding Tyr-261. Biochemistry. 2006;45(24):7415–7428.
   PubMed Web of Science ®Google Scholar
• Zhang N, Yin Y, Xu S-J, Chen W-S. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules. 2008;13(8):1551–1569.
   PubMed Web of Science ®Google Scholar
• Evdokimov NM, Van Slambrouck S, Heffeter P, Tu L, Le Calvé B, Lamoral-Theys D, Hooten CJ, Uglinskii PY, Rogelj S, Kiss R, et al. Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents. J Med Chem. 2011;54(7):2012–2021.
   PubMed Web of Science ®Google Scholar
• Radaeva M, Dong X, Cherkasov A. The use of methods of computer-aided drug discovery in the development of topoisomerase II inhibitors: applications and future directions. J Chem Inf Model. 2020;60(8):3703–3721.
   PubMed Web of Science ®Google Scholar
• Hande KR. Topoisomerase II inhibitors. Update Cancer Ther. 2008;3(1):13–26.
   Google Scholar
• Pearl LH. The HSP90 molecular chaperone—an enigmatic ATPase. Biopolymers. 2016;105(8):594–607.
   PubMed Web of Science ®Google Scholar
• Prodromou C. Mechanisms of Hsp90 regulation. Biochem J. 2016;473(16):2439–2452.
   PubMedGoogle Scholar
• Li J, Soroka J, Buchner J. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones. Biochim Biophys Acta. 2012;1823(3):624–635.
   PubMed Web of Science ®Google Scholar
• Mak OW, Sharma N, Reynisson J, Leung IKH. Discovery of novel Hsp90 C-terminal domain inhibitors that disrupt co-chaperone binding. Bioorg Med Chem Lett. 2021;38:127857.
   PubMed Web of Science ®Google Scholar
• Gaber AA, Sobhy M, Turky A, Eldehna WM, El-Sebaey SA, El-Metwally SA, El-Naggar AM, Ibrahim IM, Elkaeed EB, Metwaly AM, et al. New [1, 2, 4] triazolo [4, 3-c] quinazolines as intercalative Topo II inhibitors: design, synthesis, biological evaluation, and in silico studies. PLoS One. 2023;18(1):e0274081.
   PubMed Web of Science ®Google Scholar
• Maede Y, Shimizu H, Fukushima T, Kogame T, Nakamura T, Miki T, Takeda S, Pommier Y, Murai J. Differential and common DNA repair pathways for topoisomerase I-and II-targeted drugs in a genetic DT40 repair cell screen panel genetic screen of DNA repair for topoisomerase inhibitors. Mol Cancer Ther. 2014;13(1):214–220.
   PubMed Web of Science ®Google Scholar
• Raghavendra NM, Pingili D, Kadasi S, Mettu A, Prasad SVUM. Dual or multi-targeting inhibitors: the next generation anticancer agents. Eur J Med Chem. 2018;143:1277–1300.
   PubMed Web of Science ®Google Scholar
• Yao Q, Weigel B, Kersey J. Synergism between etoposide and 17-AAG in leukemia cells: critical roles for Hsp90, FLT3, topoisomerase II, Chk1, and Rad51. Clin Cancer Res. 2007;13(5):1591–1600.
   PubMed Web of Science ®Google Scholar
• Dutta R, Inouye M. GHKL, an emergent ATPase/kinase superfamily. Trends Biochem Sci. 2000;25(1):24–28.
   PubMed Web of Science ®Google Scholar
• Barker CR, McNamara AV, Rackstraw SA, Nelson DE, White MR, Watson AJM, Jenkins JR. Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage. Nucleic Acids Res. 2006;34(4):1148–1157.
   PubMed Web of Science ®Google Scholar
• Mohareb RM, Megally Abdo NY, Al-Darkazali WN. Uses of cyclohexan-1, 3-dione for the synthesis of thiazole, pyrazole, thiophene, isoxazole and pyran derivatives with antitumor activities. Lett Drug Des Deliv. 2020;17(5):597–609.
   Google Scholar
• Rayman MP, Infante HG, Sargent M. Food-chain selenium and human health: spotlight on speciation. Br J Nutr. 2008;100(2):238–253.
   PubMed Web of Science ®Google Scholar
• Steinbrenner H, Speckmann B, Sies H. Toward understanding success and failures in the use of selenium for cancer prevention. Antioxid Redox Signal. 2013;19(2):181–191.
   PubMed Web of Science ®Google Scholar
• Méplan C. Association of single nucleotide polymorphisms in selenoprotein genes with cancer risk. Selenoproteins Methods Protocol. 2018;1661:313–324.
   Google Scholar
• Bertz M, Kühn K, Koeberle SC, Müller MF, Hoelzer D, Thies K, Deubel S, Thierbach R, Kipp AP. Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells. Free Radic Biol Med. 2018;127:98–107.
   PubMed Web of Science ®Google Scholar
• Gladyshev VN, Arnér ES, Berry MJ, Brigelius-Flohé R, Bruford EA, Burk RF, Carlson BA, Castellano S, Chavatte L, Conrad M, et al. Selenoprotein gene nomenclature. J Biol Chem. 2016;291(46):24036–24040.
   PubMed Web of Science ®Google Scholar
• Handy DE, Loscalzo J. The role of glutathione peroxidase-1 in health and disease. Free Radical Biol Med. 2022;188:146–161.
   PubMed Web of Science ®Google Scholar
• Spengler G, et al. Organoselenium compounds as novel adjuvants of chemotherapy drugs—a promising approach to fight cancer drug resistance. Molecules. 2019;24(2):336.
   PubMed Web of Science ®Google Scholar
• Arsenyan P, Rubina K, Shestakova I, Domracheva I. 4-Methyl-1, 2, 3-selenadiazole-5-carboxylic acid amides: antitumor action and cytotoxic effect correlation. Eur J Med Chem. 2007;42(5):635–640.
   PubMed Web of Science ®Google Scholar
• Chen T, Zheng W, Wong Y-S, Yang F. Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative. Biomed Pharmacother. 2008;62(2):77–84.
   PubMed Web of Science ®Google Scholar
• Ruberte AC, Plano D, Encío I, Aydillo C, Sharma AK, Sanmartín C. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents. Eur J Med Chem. 2018;157:14–27.
   PubMed Web of Science ®Google Scholar
• Ghorab WM, El-Sebaey SA, Ghorab MM. Design, synthesis and Molecular modeling study of certain EGFR inhibitors with a quinazolinone scaffold as anti-hepatocellular carcinoma and radio-sensitizers. Bioorg Chem. 2023;131:106310.
   PubMed Web of Science ®Google Scholar
• Ghorab WM, El-Sebaey SA, Ghorab MM. Design, synthesis and molecular modeling study of certain quinazolinone derivatives targeting poly (ADP-ribose) polymerase 1 (PARP-1) enzyme as anti-breast cancer and radio-sensitizers. J Mol Struct. 2023;1273:134358.
   Web of Science ®Google Scholar
• Gomha SM, Riyadh SM, Mahmmoud EM. Synthesis and anticancer activities of thiazoles, 1, 3-thiazines, and thiazolidine using chitosan-grafted-poly (vinylpyridine) as basic catalyst. Heterocycles. 2015;91(6):1227–1243.
   Web of Science ®Google Scholar
• Gardner L, Malik R, Shimizu Y, Mullins N, ElShamy WM. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells. Breast Cancer Res. 2011;13(3):1–20.
   Web of Science ®Google Scholar
• Allan RK, Mok D, Ward BK, Ratajczak T. Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization. J Biol Chem. 2006;281(11):7161–7171.
   PubMed Web of Science ®Google Scholar
• Omar AM, Bajorath J, Ihmaid S, Mohamed HM, El-Agrody AM, Mora A, El-Araby ME, Ahmed HEA. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects. Bioorg Chem. 2020;101:103992.
   PubMed Web of Science ®Google Scholar
• Kumar CP. Synthesis and biological evaluation of 5, 10-dihydro-11H-dibenzo [b, e][1, 4] diazepin-11-one structural derivatives as anti-cancer and apoptosis inducing agents. Eur J Med Chem. 2016;108:674–686.
   PubMed Web of Science ®Google Scholar
• Lowe B, Avila HA, Bloom FR, Gleeson M, Kusser W. Quantitation of gene expression in neural precursors by reverse-transcription polymerase chain reaction using self-quenched, fluorogenic primers. Anal Biochem. 2003;315(1):95–105.
   PubMed Web of Science ®Google Scholar
• Rizvi SMD, Shakil S, Haneef M. A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians. EXCLI J. 2013;12:831.
   PubMed Web of Science ®Google Scholar
• Classen S, Olland S, Berger JM. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187. Proc Natl Acad Sci U S A. 2003;100(19):10629–10634.
   PubMed Web of Science ®Google Scholar
• Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP. Crystal structure of an Hsp90–geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 1997;89(2):239–250.
   PubMed Web of Science ®Google Scholar
• Perdew JP, Burke K, Wang Y. Generalized gradient approximation for the exchange-correlation hole of a many-electron system. Phys Rev B Condens Matter. 1996;54(23):16533–16539.
   PubMed Web of Science ®Google Scholar
• Challan S, Khater S, Rashad A. Preparation, molecular modeling and in-vivo evaluation of 99mTc-Oseltamivir as a tumor diagnostic agent. Int J Radiat Res. 2022;20(3):635–642.
   Web of Science ®Google Scholar
• Rashad AM, Mahmoud MS, El-Desawy M. FTIR and UV spectroscopic analysis of sparfloxacin combined with theoretical study based on DFT calculations. Arab J Nucl Sci Appl. 2021;54(1):51–65.
   Google Scholar
• El-Kalyoubi S, Agili F. Synthesis, in silico prediction and in vitro evaluation of antitumor activities of novel pyrido [2, 3-d] pyrimidine, xanthine and lumazine derivatives. Molecules. 2020;25(21):5205.
   PubMed Web of Science ®Google Scholar
• El-Kalyoubi S, et al. Synthesis, in silico prediction and in vitro evaluation of antimicrobial activity, dft calculation and theoretical investigation of novel xanthines and uracil containing imidazolone derivatives. Int J Mol Sci. 2021;22(20):10979.
   PubMed Web of Science ®Google Scholar
• El-Kalyoubi S, Agili F, Adel I, Tantawy MA. Novel uracil derivatives depicted potential anticancer agents: in vitro, molecular docking, and ADME study. Arab J Chem. 2022;15(4):103669.
   Web of Science ®Google Scholar
• Gandin V, Khalkar P, Braude J, Fernandes AP. Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment. Free Radic Biol Med. 2018;127:80–97.
   PubMed Web of Science ®Google Scholar
• Ueda T, Doi W, Nagai S-I, Sakakibara J. Synthesis of [1, 2, 5] selena (or thia) diazolo [3, 4‐e][1, 4] diazepines,[1, 2, 5] selena (or thia) diazolo [3, 4‐e][1, 4] oxazepines and [1, 2, 5] selena (or thia) diazolo [3, 4‐c][1, 2, 6] thiadiazines. J Heterocycl Chem. 2000;37(5):1269–1272.
   Web of Science ®Google Scholar
• Gao S, Balan B, Yoosaf K, Monti F, Bandini E, Barbieri A, Armaroli N. Highly efficient luminescent solar concentrators based on benzoheterodiazole dyes with large stokes shifts. Chemistry. 2020;26(48):11013–11023.
   PubMed Web of Science ®Google Scholar
• Dhanjal S, Cameotra SS. Aerobic biogenesis of selenium nanospheres by Bacillus cereus isolated from coalmine soil. Microb Cell Fact. 2010;9(1):52.
   PubMedGoogle Scholar
• Delgado JL, Hsieh C-M, Chan N-L, Hiasa H. Topoisomerases as anticancer targets. Biochem J. 2018;475(2):373–398.
   PubMedGoogle Scholar
• Lianos GD, Alexiou GA, Mangano A, Mangano A, Rausei S, Boni L, Dionigi G, Roukos DH. The role of heat shock proteins in cancer. Cancer Lett. 2015;360(2):114–118.
   PubMed Web of Science ®Google Scholar
• Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol. 2016;37(7):8471–8486.
   PubMed Web of Science ®Google Scholar
• Zuehlke AD, Beebe K, Neckers L, Prince T. Regulation and function of the human HSP90AA1 gene. Gene. 2015;570(1):8–16.
   PubMed Web of Science ®Google Scholar
• Sordet O, Khan QA, Kohn KW, Pommier Y. Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anticancer Agents. 2003;3(4):271–290.
   PubMedGoogle Scholar
• Hong T-J, Park H, Kim Y-J, Jeong J-H, Hahn J-S. Identification of new Hsp90 inhibitors by structure-based virtual screening. Bioorg Med Chem Lett. 2009;19(16):4839–4842.
   PubMed Web of Science ®Google Scholar
• Koopmans T. Ordering of wave functions and eigenenergies to the individual electrons of an atom. Physica. 1934;1(1-6):104–113.
   Google Scholar
• Parr RG, Szentpály Lv, Liu S. Electrophilicity index. J Am Chem Soc. 1999;121(9):1922–1924.
   Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):1–13.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev. 1997;23(1-3):3–25.
   Web of Science ®Google Scholar
• Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43(20):3714–3717.
   PubMed Web of Science ®Google Scholar
• Ali J, Camilleri P, Brown MB, Hutt AJ, Kirton SB. In silico prediction of aqueous solubility using simple QSPR models: the importance of phenol and phenol-like moieties. J Chem Inf Model. 2012;52(11):2950–2957.
   PubMed Web of Science ®Google Scholar
• Daina A, Zoete V. A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11(11):1117–1121.
   PubMed Web of Science ®Google Scholar
• Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5–W14.
   PubMed Web of Science ®Google Scholar
• Wang S, Sun H, Liu H, Li D, Li Y, Hou T. ADMET evaluation in drug discovery. 16. Predicting hERG blockers by combining multiple pharmacophores and machine learning approaches. Mol Pharm. 2016;13(8):2855–2866.
   PubMed Web of Science ®Google Scholar